2019 annual financial data
Summit Therapeutics 2019 Operating margin
Direct answer
Operating margin was 35.24%.
Operating income was 15,156,000 GBP and net income was 4,994,000 GBP.
Operating cash flow was -26,663,000 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 43,012,000 GBP
- Operating income
- 15,156,000 GBP
- Net income
- 4,994,000 GBP
- Operating cash flow
- -26,663,000 GBP